Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D-ID
Warren, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
3D Biotek supplies commercialized 3D porous scaffolds ("3D Insert") and is developing a fully automated 3D Cell Expansion System (3D-CES) for large-scale cell expansion, with applications in stem cell therapy and drug screening. No therapeutics/clinical results—company specializes in tools and devices, not direct drug development.
- Therapeutic areas
- HematologyOther
- Modalities
- Device3D cell culture scaffoldInstrument/device for cell therapy support
- Industry
- Therapeutic Medical Devices
02
Partnerships
Distribution agreement with Sigma-Aldrichacademic collaborations (e.g., Cancer Center of Hackensack University)
Beyond the preview
Go deeper on 3D-ID.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3D-ID.